| Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320) |
|---|
| 02/03/2005 | US20050027103 Matrix protein for use diagnosis, treatment, and prevention of viral infections, cell proliferative and neurological disorders |
| 02/03/2005 | US20050026974 Immunogenic conjugates of nitroaromatic compounds and proteins; monoclonal antibodies specific for nitroaromatic compounds , their protein conjugates |
| 02/03/2005 | US20050026854 Antibody is used to prevent, or treat of graft versus host disease; Antibody dependent cellular cytotoxicity; anti-sense nucleic acid; graft-versus-tumor activity and immunotherapy |
| 02/03/2005 | US20050026837 Novel proteins and methods for producing the proteins |
| 02/03/2005 | US20050026826 Feline proinsulin, insulin and constituent peptides |
| 02/03/2005 | US20050026303 Monoclonal antibodies specific for crack cocaine metabolites, a cell line producing the same, and crack cocaine conjugates |
| 02/03/2005 | US20050026284 Nuclease inhibitor cocktail |
| 02/03/2005 | US20050026271 subunit vaccines for dental caries; rather than using intact GTF as an immunizing agent, the vaccine is prepared from particular immunogenic portions (subunits) of GTF |
| 02/03/2005 | US20050026263 Multi-functional antibodies |
| 02/03/2005 | US20050026257 Injecting Dna containing virus codes into mammal; testing serum for antibodies ; cloning genes |
| 02/03/2005 | US20050026252 Expression vector comprising rodent regulatory sequences for use as gene expression control tools in genetic engineering |
| 02/03/2005 | US20050026246 Method for generating diversity |
| 02/03/2005 | US20050026232 Monoclonal antibody which preferentially binds leukocyte common antigen-related molecule phosphatase (LAR) for use in diagnosis, prevention and treatment of cell proliferative disorders |
| 02/03/2005 | US20050026229 Cell line for use in generating monoclonal antibodies specific for prostate stem cell antigen (PSCA) for use in diagnosis of cell proliferative disorders; immunodiagnostics |
| 02/03/2005 | US20050026226 Serum Paraoxonase |
| 02/03/2005 | US20050026222 Antitumor antibodies, proteins, and uses thereof |
| 02/03/2005 | US20050026215 Method for the prediction of an epitope |
| 02/03/2005 | US20050026211 Compositions and methods relating to lung specific genes |
| 02/03/2005 | US20050026182 Human CDNAS and proteins and uses thereof |
| 02/03/2005 | US20050026169 Using presence of single nucleotide polymorphism in apopoliprotein gene sequences as diagnostic indicator of cardiovascular disorders |
| 02/03/2005 | US20050025784 Compositions and methods for enhancing immune responses mediated by antigen-presenting cells |
| 02/03/2005 | US20050025775 Contacting a sample with an isolated monoclonal antibody that binds to a substantially-pure coagulase-negative Staphylococcus epidermidis capsular polyssocharide adhesin antigen that binds to polymeric material, wherein said adhesin antigen inhibits binding to polymeric material |
| 02/03/2005 | US20050025773 Blocked immunoglobulin comprising antibody portion having heavy or light chain variable region; and Protein A portions; tethered to solid support; antibody sandwich, enzyme-linked immunosorbent, antibody dipstick, antibody microarray, radioimmuno-, or rolling circle amplification assay |
| 02/03/2005 | US20050025772 Monoclonal antibody 108-394 binds to shared epitope of protein p24 and protein p26; diagnostic kits; conjugate of antibody attached to a signal generating compound; sensitivity |
| 02/03/2005 | US20050025771 Antitumor agents comprising a targeting portion and an immune response triggering portion |
| 02/03/2005 | US20050025770 Immunological methods for the treatment of gastrointestinal cancer |
| 02/03/2005 | US20050025768 Antigen binding fragments (fab fragments) binds to a plurality of beta-chemokines; glomerulonephritis, scleroderrna, cirrhosis, multiple sclerosis, lupus nephritis, atherosclerosis, inflammatory bowel disease or rheumatoid arthritis; antiinflammatory agents |
| 02/03/2005 | US20050025767 Contains antibody binding to macrophage migration inhibitory factor |
| 02/03/2005 | US20050025764 CD20 binding molecules |
| 02/03/2005 | US20050025763 Therapeutic use of anti-CS1 antibodies |
| 02/03/2005 | US20050025762 Methods of diagnosing and treating pre-eclampsia or eclampsia |
| 02/03/2005 | US20050025761 immunoconjugate and duramycin-based compositions and combinations that bind and inhibit anionic phospholipids and aminophospholipids, for use in the safe and effective treatment of cancer, viral infections and related diseases |
| 02/03/2005 | US20050025760 Pemphigus monoclonal antibody |
| 02/03/2005 | US20050025744 Administration of humanized anti-IP-10 antibody in combination with beta-interferon 1a, beta-interferon 1b, glatiramer acetate, or humanized anti-VLA-4-antibody |
| 02/03/2005 | DE10331054A1 New emitter-binding peptide, useful for in vitro diagnosis of e.g. antigens, binds to an emitter to change its spectral emission properties, also related nucleic acid, vectors, cells and antibodies |
| 02/03/2005 | DE10328121A1 Passive Immuntherapie gegen malignes Melanom Passive immunotherapy against malignant melanoma |
| 02/03/2005 | CA2536644A1 Antibodies and uses thereof |
| 02/03/2005 | CA2533849A1 Aminated complex-type sugar chain derivatives and process for the production thereof |
| 02/03/2005 | CA2533503A1 Antibodies to the fbsa protein of streptococcus agalactiae and their use in treating or preventing infections |
| 02/03/2005 | CA2533113A1 Soluble fragments of the sars-cov spike glycoprotein |
| 02/03/2005 | CA2532547A1 Methods and compositions for increasing the efficiency of therapeutic antibodies using nk cell potentiating compounds |
| 02/03/2005 | CA2532430A1 Humanized versions of monoclonal antibody ds6 that bind tumour antigen ca6 |
| 02/03/2005 | CA2532394A1 Rg1 antibodies and uses thereof |
| 02/03/2005 | CA2531491A1 Agonist polypeptide of receptor for zot and zonulin |
| 02/03/2005 | CA2530285A1 Antibodies directed to the deletion mutants of epidermal growth factor receptor and uses thereof |
| 02/03/2005 | CA2530284A1 Il-17 a/f heterologous polypeptides and therapeutic uses thereof |
| 02/03/2005 | CA2530085A1 Compositions and methods for the production of betaine lipids |
| 02/03/2005 | CA2528440A1 Replikin peptides and uses thereof |
| 02/03/2005 | CA2526240A1 7a5/prognostin and use thereof for the diagnostic and therapy of tumors |
| 02/03/2005 | CA2517600A1 Methods and compositions for the treatment and prevention of staphylococcus and other bacterial infections |
| 02/02/2005 | EP1503212A1 Methods for diagnosis and therapy of cancer and composition useful therein |
| 02/02/2005 | EP1502920A2 Cell surface molecule mediating cell adhesion and signal transmission |
| 02/02/2005 | EP1502603A1 DRUG CONTAINING ANTIBODY COMPOSITION APPROPRIATE FOR PATIENT SUFFERING FROM Fc gamma RIIIa POLYMORPHISM |
| 02/02/2005 | EP1502602A2 Methods for therapeutic vaccination |
| 02/02/2005 | EP1502116A2 Screening for peptides inhibiting pp1c binding to bcl-2, bcl-xl and bcl-w proteins |
| 02/02/2005 | EP1501936A2 Cytokine protein family |
| 02/02/2005 | EP1501871A2 Isolated human proteins that show high homology to human disease proteins, nucleic acid molecules encoding these human proteins, and uses thereof |
| 02/02/2005 | EP1501870A2 Rsv proteins, antibodies, compositions, methods and uses |
| 02/02/2005 | EP1501869A2 Phosphorylated histone h2b as an apoptosis marker |
| 02/02/2005 | EP1501857A2 Novel pancortin-pablo protein interactions and methods of use thereof |
| 02/02/2005 | EP1501856A2 Anti-her2 antibody variants |
| 02/02/2005 | EP1501855A2 Novel compositions and methods in cancer |
| 02/02/2005 | EP1501852A2 Regeneration of endogenous myocardial tissue by induction of neovascularization |
| 02/02/2005 | EP1501545A2 Use of tnfalpha antibodies and another drug |
| 02/02/2005 | EP1501544A2 Alcam and alcam modulators |
| 02/02/2005 | EP1501538A2 Use of alpha-s2 casein precursor-derived peptides |
| 02/02/2005 | EP1501531A1 Method for treating anxiety and mood disorders in older subjects |
| 02/02/2005 | EP1501524A2 Internal image antibodies for optical imaging and therapy |
| 02/02/2005 | EP1501369A2 Non-affinity purification of proteins |
| 02/02/2005 | EP1501359A2 Compositions comprising immunostimulatory oligonucleotides and uses thereof to enhance fc receptor-mediated immunotherapies |
| 02/02/2005 | EP1432810A4 Production of recombinant proteins in vivo and use for generating antibodies |
| 02/02/2005 | EP1432451A4 Production of fusion proteins and use for identifying binding molecules |
| 02/02/2005 | EP1415002B1 Focussed antibody technology |
| 02/02/2005 | EP1266025A4 Protein scaffolds for antibody mimics and other binding proteins |
| 02/02/2005 | EP1242601B1 Trichoderma reesei xylanase |
| 02/02/2005 | EP1135166B9 Hapten-carrier conjugates for treating and preventing nicotine addiction |
| 02/02/2005 | EP1092040B1 Methods of inhibiting helicobacter pylori |
| 02/02/2005 | EP0981610B1 Compositions for treatment of disorders involving programmed cell death |
| 02/02/2005 | EP0826031B1 Ataxia-telangiectasia gene and its genomic organization |
| 02/02/2005 | EP0757557B1 Methods for inducing t cell tolerance to a tissue or organ graft |
| 02/02/2005 | EP0741788B1 Inducing tolerance with tolerogenic fusion proteins |
| 02/02/2005 | EP0705110B1 Immunoglobulin infusion in xenotransplantation |
| 02/02/2005 | CN1575337A Mammalian receptor proteins; related reagents and methods |
| 02/02/2005 | CN1575303A Human CDR-grafted antibodies and antibody fragments thereof |
| 02/02/2005 | CN1575302A Human tissue factor antibodies |
| 02/02/2005 | CN1575299A Homing peptides |
| 02/02/2005 | CN1575184A Method and composition for treating immune complex associated disorders |
| 02/02/2005 | CN1572800A Specific antibody of tumor-associated antigen SM5-1 and use thereof |
| 02/02/2005 | CN1572798A SARS coronary virus related polypeptide and its uses |
| 02/02/2005 | CN1572325A Treatment of lupus nephritis with anti-CD40L compounds |
| 02/02/2005 | CN1187374C Humanized antibody specific for human 4-1BB and pharmaceutical compsn comprising same |
| 02/02/2005 | CN1187373C Human resourced monoclone antibody of anti-blood-vessel endothelium growth factor as well as its preparing method and medicine composition |
| 02/02/2005 | CN1187370C Connective tissue growth factor fragments and methods and uses thereof |
| 02/02/2005 | CN1187086C Hybrid with interferon alpha and immunoglobulin Fc linked through non-immunogenic peptide |
| 02/02/2005 | CN1187084C Use of alpha1 & beta1 integrin receptor inhibitors and TGF-beta1 inhibitors in the treatment of kidney disease |
| 02/01/2005 | US6849720 Monoclonal antibodies to the human LDL receptor, their production and use |
| 02/01/2005 | US6849719 Antibody to an IL-17 receptor like protein |
| 02/01/2005 | US6849718 Muteins of hypoxia inducible factor alpha and methods of use thereof |
| 02/01/2005 | US6849715 Agents useful for inactivation of Ras subfamily proteins |
| 02/01/2005 | US6849601 A conotoxin proteins is adrenergic blocking agents, treating disorders of urinary or cardiovascular conditions, having alpha 1-adrenoceptor antagonist activity |